The T-cell type lymphoid malignancies were heterogenous disease. A classification of T-cell type lymphoid malignancies was proposed as based on clinical, cytological and immunological analysis of the disease.
1. Thymus (+), lymphoblastic type
2. Thymus (-), lymphoblastic and/or lymphocytic type
3. Adult, pleomorphic type
4. IBL-like or Hodgkinoid type
The characteristics of each disease is summarrized as follow; 1) Thymus (+), lymphoblastic type—The disease usually developed predominantly in young male (less than 30 years old) with thymus enlargement and was progressive with high incidence of CNS involvement and leukemic manifestation. Tumor cells had high TdT activity, T-cell specific antigen, En-rosette forming capacity (En-RFC) and freguently C
3-d receptor. 2) Thymus (-), lymphoblastic and/or lymphocytic type—The disease developed predominantly in male without specific age distribution. Thymus enlargement was not detected throughout the course. Tumor cells had low TdT activity, En-RFC, T-cell specific antigen occasionally with Fcγ-receptor. About 80% of the patients, who had lymphoblastic or mixed cell morphology, had poor prognosis, while 20% of the patients, who all showed lymphocytic or CLL morphology, survived longer. 3) Adult, pleomorphic type—The disease usually developed in older people (more than 20 years old) with slight predominance in male. More than half of patients came from Kyushu districts. About 20∼30% of patients was accompanied with hypercalcemia, eosinophilia, interstitial pneumonitis and Herpes Zoster. High incidence of skin involvement and leukemic manifestation without thymus involvement was characteristics of the disease. Tumor cells showed bizarre and pleomorphic appearances and had low TdT activity, T-cell specific antigen and En-RFC. C
3 and Fcγ-receptors were not detected. About 60% of patients died early, but 30∼40% of patients were alive for longer period. 4) IBL-like or Hodgkinoid type—This group of patients was diagnosed histopathologically as likely immunoblastic lymphadenopathy or Hodgkinoid. However, cytology of aspirates from lymphnodes revealed many tumor cells with atypical morphology, which always carried T-cell marker. We tentatively classified these cases as “IBL-like or Hodgkinoid” type.
The approprieteness of the new classification of T-cell type lymphoid malignancies according to phenotype of immunological markers, morphological characteristics and clinical features and their presumed origin is discussed.
抄録全体を表示